<DOC>
	<DOCNO>NCT00744965</DOCNO>
	<brief_summary>This randomize prospective trial address question whether use oral hypoglycemic agent adjunct diet therapy woman mild gestational diabetes result achieve euglycemia short period time , turn , result le frequent maternal neonatal morbidity . This study design test hypothesis woman mild GDM , use Glyburide addition diet nutritional counseling lower mean infant birth weight 200 gram compare diet nutritional counseling alone .</brief_summary>
	<brief_title>Treatment Mild Gestational Diabetes With Glyburide Versus Placebo</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Glyburide</mesh_term>
	<criteria>A glucose value ≥140 mg/dl 50gram oral glucose load test plasma gestational age 24 week 0 day 27 week 6 day base clinical information An Abnormal 3hour oral glucose tolerance test fast glucose ≤105 mg/dl Gestational age less equal 28 week 0 day time consent/randomization Singleton gestation Established pregestational diabetes Abnormal gestational diabetes test ( ≥140 ) prior 24 week 0 day gestation . Women negative glucose load test ( &lt; 140mg/dl ) 24 week may still consider study present glucose tolerance test 24 27 week . Multiple gestation Known major fetal anomaly fetal demise Any renal disease serum creatinine &gt; 1.0 Known liver disease hepatitis Maternal fetal condition likely require imminent preterm delivery preeclampsia , preterm premature rupture membrane , preterm labor , intrauterine fetal growth restriction Known hypersensitivity allergic reaction Glyburide</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>